During the past decade, Zentrum für Gynäkologische Onkologie conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Zentrum für Gynäkologische Onkologie" #1 collaborator was "ARCAGY/ GINECO GROUP" with 1 trials as a collaborator, "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 1 trials as a collaborator, "Australia New Zealand Gynaecological Oncology Group" with 1 trials as a collaborator and "Scottish Gynaecological Cancer Study Group" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Zentrum für Gynäkologische Onkologie" are "BRCA Status" (1 trials), "Ovarian Cancer" (1 trials) and "Recurrent Platinum-sensitive Ovarian Cancer" (1 trials). Many other conditions were trialed in "Zentrum für Gynäkologische Onkologie" in a lesser frequency.

Most popular intervention types in "Zentrum für Gynäkologische Onkologie" are "Biological" (1 trials), "Drug" (1 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (1 trials), "Carboplatin" (1 trials), "PLD" (1 trials) and "Testing of BRCA status regarding germline and somatic mutation" (1 trials). Other intervention names were less common.

The vast majority of trials in "Zentrum für Gynäkologische Onkologie" are 2 trials for "Female" genders.

Currently, there are NaN active trials in "Zentrum für Gynäkologische Onkologie". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Zentrum für Gynäkologische Onkologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Zentrum für Gynäkologische Onkologie, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".